Aethlon Medical raises authorized shares to 200M

Stockholders approved the amendment at the October 1, 2026 annual meeting.

Rhea-AI Filing Summary

Aethlon Medical, Inc. (AEMD) increased its authorized common stock from 20,000,000 shares to 200,000,000 shares, effective October 7, 2026. Stockholders approved the amendment at the October 1, 2026 annual meeting. The amendment changes Article V of the company’s Articles of Incorporation; the common stock has a $0.001 par value per share.

Filing Explained

Now effective, the amendment expands the company’s authority to issue common shares, but the authorization itself is not an issuance; if shares are issued, existing holders’ ownership percentages fall absent offsetting changes.

8-K Event Classification

2 items: 5.03, 9.01

2 items

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Governance

The company amended its charter documents, bylaws, or changed its fiscal year.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Authorized common shares: 200,000,000 shares Previously authorized common shares: 20,000,000 shares Common stock par value: $0.001 per share

3 metrics

Authorized common shares 200,000,000 shares Effective October 7, 2026

Previously authorized common shares 20,000,000 shares Before the amendment

Common stock par value $0.001 per share Common stock

Key Terms

authorized shares, par value, Articles of Incorporation

3 terms

authorized shares regulatory

"increase the number of authorized shares"

Authorized shares are the maximum number of shares a company is allowed to issue according to its official plan. Think of it as a company’s set limit on how many pieces of its ownership it can distribute to investors. This number helps investors understand the potential for future growth or change in the company's ownership structure.

par value financial

"common stock, par value $0.001 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

Articles of Incorporation regulatory

"amendment to the Company's Articles of Incorporation"

A formal legal document filed with a government authority that creates a corporation and sets its basic rules — for example the company name, business purpose, how many ownership shares can exist, and who can receive legal notices. It matters to investors because it defines ownership structure, voting rights, and limits on liability, shaping who controls the company and how future shares or dividends can affect an investor’s stake; think of it as the company’s birth certificate and rulebook.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many common shares has AEMD authorized?

Aethlon Medical authorized 200,000,000 shares of common stock, up from 20,000,000 shares, effective October 7, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/09/2026 - 04:15 PM Accepted by SEC EDGAR 10/09/2026 - 04:15 PM Learn about SEC filing dates

false --03-31 0000882291 0000882291 2026-10-07 2026-10-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 7, 2026

Aethlon Medical, Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-37487		13-3632859
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

11555 Sorrento Valley Road, Suite 203 San Diego, California		92121
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (619) 941-0360

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value per share		AEMD		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

As previously reported, at the 2026 Annual Meeting of Stockholders of Aethlon Medical, Inc. (the "Company") held on October 1, 2026, the Company's stockholders approved an amendment to the Company's Articles of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock, par value $0.001 per share, from 20,000,000 shares to 200,000,000 shares (the "Articles Amendment").

The Articles Amendment was filed with the Secretary of State of the State of Nevada and became effective on October 7, 2026, and amends Article V of the Company’s Articles of Incorporation to authorize an aggregate of 200,000,000 shares of common stock, par value $0.001 per share.

A copy of the Articles Amendment is filed herewith as Exhibit 3.1 and incorporated herein by reference. The foregoing summary of the Articles Amendment does not purport to be complete and is qualified in its entirety by reference to such exhibit. 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
3.1		Certificate of Amendment to the Articles of Incorporation of Aethlon Medical, Inc., as filed with the Secretary of State of the State of Nevada on October 7, 2026
104		Cover Page Interactive Data File (embedded within the inline XBRL Document)

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 9, 2026	AETHLON MEDICAL, INC.
	By:	/s/ James B. Frakes
	Name: Title:	James B. Frakes Chief Executive Officer and Chief Financial Officer

3

Filing Exhibits & Attachments

4 documents

Other Documents

• EX-3.1 CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION OF AETHLON MEDICAL, IN 9.1 KB
• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB